Sustainable portfolios

Wir stellen uns eine Zukunft vor, in der die Menschen optimale Gesundheit und Wohlbefinden genießen, in der die Gesundheitssysteme effizient und verantwortungsbewusst arbeiten, mit minimalen Kosten für die Umwelt und mit positiven Auswirkungen auf die Gesellschaft als Ganzes.
Um diese Vision einer nachhaltigen Gesundheitsversorgung zu erreichen, bedarf es eines ganzheitlichen Ansatzes, der die ökologischen, sozialen und ökonomischen Aspekte der Versorgung berücksichtigt. Diese Vision ist der Antrieb für eine strenge Bewertung unseres Produktportfolios in Bezug auf diese entscheidenden Aspekte und unsere kontinuierlichen Bemühungen um Verbesserungen, ohne die Sicherheit und Qualität unserer Produkte zu beeinträchtigen.
Wir entwickeln ständig Innovationen mit dem Ziel, unseren Kunden die nachhaltigsten Lösungen anzubieten, ohne Kompromisse bei der Sicherheit und Qualität unserer Produkte einzugehen.

Die Lebenszyklusperspektive ist eine wichtige Grundlage für die Arbeit von Mölnlycke zur Verbesserung der Nachhaltigkeit. Es stellt sicher, dass wir die gesamte Wirkung eines Produkts oder einer Dienstleistung berücksichtigen, von den Rohstoffen bis zum fertigen Produkt, während des Gebrauchs und am Ende der Lebensdauer.
-
Our position statement on Life Cycle Assessment
The benefits of a Life Cycle Assesment are twofold:
- They inform internal decision making, ensure that continual improvement projects focus on the highest impact areas and do not cause unintended negative impacts, securing the best route for innovation, toward the sustainable solution that both our customers and internal governance require.
- If they are conducted to a high and consistent standard, they enable customers to more accurately reflect their enviornmental impact, and understand where they too can focus improvement.
When making sustainability claims through LCA comparisons of products and services, Mölnlycke adheres to the following principles:
- Employ the same methodology, assumptions, and scope used for measuring our own products, guaranteeing an equitable comparison within our portfolio.
- Compare the product being evaluated with the average product from our portfolio, rather than with competitors', to underscore improvements and avoid misleading claims.
- Where available, utilize Product Category Rules (PCRs) relevant to the product category. Based on ISO 14040, ISO 14044, ISO 14025 PCRs define the guidelines for creating an Environmental Product Declaration (EPD) for a specific category and may include industry averages for comparison.
In making sustainability claims, transparency and accuracy are paramount for Mölnlycke. To avoid the risks of "greenwashing" and potential harm to our reputation, it's crucial that our claims are substantiated by reliable data and adhere to pertinent guidelines and standards.
Individual product Life Cycle Assessments inform our work with a holistic sustainability assessment of our portfolio that we conduct in a systematic manner aligned with standardised methodology.
-
Our position statement on Sustainable Product Portfolio Assessment (SPPA)
Mölnlycke is actively engaged in promoting a circular economy, incorporating circular practices throughout its entire value chain. Mölnlycke recognises the transformative possibilities across every facet of its business with a collaborative focus on providing its customers with sustainable solutions that utilise resources responsibly and create a minimal environmental impact, while delivering the optimum positive societal impact.
Mölnlycke adapted the standardised categorisation methodology, Sustainable Product Portfolio Assessment, from the portfolio framework tool developed by World Business Council for Sustainable Development (WBCSD) as fit for purpose for a MedTech company.
The company’s portfolio approach promotes the use of safer and more sustainable products, compared to mainstream products or services available on the market, in all stages of the value chain. Mölnlycke’s responsibility stretches to the whole life cycle, from sourcing, transportation, manufacturing through to customer use and end of life. The company assesses the sustainability performance of all products and services and builds sustainability thinking into its innovation process through sustainable design insights and eco-design tools.
Mölnlycke segments its product portfolio into the following three categories to reflect the sustainability risks and opportunities.
- “Leading solutions” are solutions that offer significant sustainability benefits for customers compared to mainstream alternatives in the market, while providing the same or better functionality and no adverse impacts on any other sustainability criteria.
- “Performers” are solutions which meet the needs of Mölnlycke’s customers and patients and have no immediate positive or negative impact in terms of sustainability.
- “Transitioners” are solutions which have known current or future sustainability risks, according to regulations or concerns raised by stakeholders such as customers, NGOs, and public groups.
Information from the portfolio analysis is used to support product portfolio planning through the company’s marketing and innovation processes. It also helps the company to engage with customers with a focus on sustainability.

"Die Durchführung eines Sustainable Product Portfolio Assessment (SPPA) verschafft uns ein tiefes Verständnis für die in unserem Portfolio verankerte Nachhaltigkeit. Dies ermöglicht es uns nicht nur, Kunden zu nachhaltigen Entscheidungen zu führen, sondern bereichert auch unsere Erkenntnisse für die kontinuierliche Weiterentwicklung widerstandsfähiger und nachhaltiger Lösungen."
Erik van Campenhout Kaufmännischer Direktor EMEA/APAC/Globales Geschäft. Entwicklung und globales Marketing, Antiseptika
Criteria we take into consideration when assessing the sustainability benefits of our products


Gefährliche Stoffe
In Medizinprodukten wird häufig eine Vielzahl chemischer Materialien verwendet, darunter Kunststoffe, Klebstoffe und Beschichtungen. Einige dieser Materialien können gefährliche Substanzen wie Weichmacher, Flammschutzmittel und antimikrobielle Mittel enthalten.
Wir identifizieren, klassifizieren, bewerten und verwalten proaktiv alle Stoffe, um sicherzustellen, dass potenzielle Gefahren identifiziert werden. Einmal identifiziert, werden alle Gefahren sorgfältig kontrolliert und gemindert. Ein besonderer Fokus liegt dabei auf Substanzen, die gefährlich sein können. Wir verpflichten uns, gefährliche Stoffe zu minimieren und zu ersetzen, wann immer dies möglich ist.
-
Our position statement on hazardous substances
Creating solutions to achieve optimal healthcare outcomes often requires complex production processes and the handling of many different substances. Mölnlycke is committed to the safe use of all substances at every stage of design and production. We systematically identify, classify, and assess the risks of all substances to ensure that potential hazards are identified and controlled.
Our program continually reviews substances as their regulatory status changes and prevents the introduction of hazardous substances into our operations. The output from our hazardous substance assessment program is fully integrated into our Sustainable Product Portfolio Assessment (SPPA) process, which is implemented across most Mölnlycke businesses. This direct link ensures timely and appropriate management of identified substances within our product portfolio.
We focus particularly on substances that are hazardous or may be hazardous in the future, aiming to minimise and replace them whenever possible. This process is embedded in rigorous review and rating systems, along with portfolio-level analysis and reporting, to ensure the continual removal of hazardous substances from our value chain. Our ongoing program of research, development, and supplier interaction seeks technologies to replace these substances. When replacement is not feasible, hazardous substances may only be used when their safe use and adequate controls can be demonstrated, protecting our teams, stakeholders, and the environment.
Careful handling of hazardous substances and preventing their release into the environment are requirements of the ISO 45001 standard for occupational health and safety management and the ISO 14001 standard for environmental management. Mölnlycke is globally certified to these standards and regularly audited by an accredited body to ensure conformance.

Entwicklung von Produkten mit längerer Lebensdauer
Unterstützung von Kunden bei der Abfallreduzierung
Studien zeigen, dass der Wechsel von einfach verpacktem medizinischem Zubehör zu unseren anpassbaren Mölnlycke® ProcedurePak-Trays den Verpackungsabfall um bis zu 90 % reduzieren und gleichzeitig wertvolle Zeit bei der Vorbereitung sparen kann.

Erneuerbare Alternativen zu fossilen Materialien
Im Rahmen unseres Engagements für eine effiziente Materialnutzung und die Unterstützung der Prinzipien der Kreislaufwirtschaft ist Mölnlycke stolz darauf, das Lösungsportfolio um erneuerbare Materialien zu erweitern, die nach dem International Sustainability and Carbon Certification System (ISCC) zertifiziert sind.
Mehrere Ökobilanzen von Mölnlycke zeigen, dass der Ersatz von fossilem Kunststoff durch ISCC-zertifiziertes biobasiertes Material zu einem Produkt mit geringeren Treibhausgasemissionen führen kann.
- Van Overschelde P, et al. Undisturbed wound healing: a single centre retrospective study investigating patient reported outcomes and clinical validity of extended dressing wear time for incisional healing following orthopaedic surgery. The ARCTIS study. Journal of Wound Care, 2024.